Acro Biomedical (ACBM) Deferred Taxes (2018 - 2019)

Acro Biomedical (ACBM) recorded quarterly Deferred Taxes of -$73071.0 in Q3 2019, little changed quarter-over-quarter from -$73071.0 in Q2 2019.

Acro Biomedical (ACBM) Deferred Taxes (2018 - 2019) Analysis & Trends

Acro Biomedical's Deferred Taxes history runs 2 years deep, the most recent figure standing at -$73071.0 for Q3 2019.

In Q3 2019, Deferred Taxes changed N/A year-over-year to -$73071.0; the TTM figure through Sep 2020 stood at -$101018.0 (down 24.6% YoY), while the FY2019 annual figure was -$19941.0, changed N/A from the prior year.
Deferred Taxes was -$73071.0 for Q3 2019 at Acro Biomedical, roughly flat from -$73071.0 in the prior quarter.
In the past five years, Deferred Taxes ranged from a high of $45124.0 in Q1 2019 to a low of -$73071.0 in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	EQV Ventures Acquisition	477.93 Mn	477.93 Mn	-	-
2	GP-Act III Acquisition	312.80 Mn	312.80 Mn	-	-
3	Berto Acquisition	311.56 Mn	311.56 Mn	-	-
4	Churchill Capital Corp IX	310.79 Mn	310.79 Mn	-	-
5	Centurion Acquisition	310.21 Mn	310.21 Mn	-	-
6	WEN Acquisition	309.15 Mn	309.15 Mn	-	-
7	Agriculture & Natural Solutions Acquisition	303.81 Mn	303.81 Mn	-	-
8	Bold Eagle Acquisition	274.64 Mn	274.64 Mn	-	-
9	Live Oak Acquisition Corp. V	265.88 Mn	265.88 Mn	-	-
10	Acro Biomedical	-	-	-	-

Download Data